Bio-Path Holdings, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Bio-Path Holdings, Inc. (BPTH) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $3.50 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2025-03-27
- Bio-Path Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $3.50M, a 85.54% decline from fiscal 2023.
- Bio-Path Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $24.20M, a 26.70% increase from fiscal 2022.
- Bio-Path Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $19.10M, a 0.53% increase from fiscal 2021.
- Bio-Path Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $19.00M, a 15.85% increase from fiscal 2020.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2024-12-31 | $3.50M 10-K · filed 2025-03-27 |
| 2023-12-31 | $24.20M 10-K · filed 2024-03-07 |
| 2022-12-31 | $19.10M 10-K · filed 2024-03-07 |
| 2021-12-31 | $19.00M 10-K · filed 2023-03-30 |
| 2020-12-31 | $16.40M 10-K · filed 2022-03-10 |
| 2019-12-31 | $13.40M 10-K · filed 2021-03-09 |
| 2018-12-31 | $11.40M 10-K · filed 2020-03-05 |
| 2017-12-31 | $9.50M 10-K · filed 2019-03-19 |
| 2016-12-31 | $11.00M 10-K · filed 2018-04-02 |